ARMA: An Innovative, Minimally Invasive Treatment for Acid Reflux

Posted July 22, 2026

If you’ve been living with acid reflux, you know the drill: avoid trigger foods, prop up your pillows, and take a pill every morning hoping it does the job. For most people with gastroesophageal reflux disease (GERD), proton pump inhibitors (PPIs) and lifestyle changes are enough. But for a meaningful share of patients, symptoms persist even with daily medication — and that’s where newer endoscopic options like ARMA (Anti-Reflux Mucosal Ablation) come in.

The Treatment Gap in GERD

GERD is typically managed in three tiers:

Lifestyle changes — weight loss, elevating the head of the bed, avoiding late meals
Medications — PPIs, H2 blockers, and antacids
Surgery — laparoscopic Nissen fundoplication, the long-standing surgical gold standard

The problem is the space between medication and surgery. A significant portion of GERD patients don’t get full relief from PPIs, but aren’t necessarily ready for — or good candidates for — a full surgical fundoplication. This is the gap that endoscopic anti-reflux procedures like ARMA were developed to fill.

What Is ARMA?

ARMA is a minimally invasive, endoscopic procedure performed entirely through the mouth, with no external incisions. Instead of wrapping or reinforcing the area mechanically like surgery does, ARMA works by using controlled thermal energy to ablate (treat) the mucosal tissue at the gastroesophageal junction — where the esophagus meets the stomach.

This creates a controlled, ulcer-like injury that heals over the following weeks into scar tissue. That scarring tightens and reshapes the tissue flap at the junction, reinforcing it as a natural barrier against reflux. The effect isn’t immediate — most patients see improvement over one to two months, as the healing and scarring process completes.

What the Evidence Shows

ARMA was pioneered by Dr. Haruhiro Inoue and colleagues, initially as a pilot study for patients with GERD that was refractory to PPIs. Since then, larger studies and international multi-center research have followed. Reported outcomes generally include:

Meaningful reductions in acid exposure time and DeMeester scores (a standard measure of reflux severity)
Clinical success rates cited around 70%+ at one year in some studies
A generally favorable safety profile, with the most common complication being temporary narrowing (stenosis) at the treatment site, which is manageable with endoscopic dilation if it occurs

Because it’s newer than surgical fundoplication, researchers are still working out long-term durability data and which patients are the best candidates — but the overall trend in the literature is encouraging.

Who Might Be a Candidate

ARMA is generally being explored for patients who:

Have confirmed GERD that hasn’t fully responded to PPI therapy
Want to avoid or delay a more invasive surgical procedure
Have a hiatal hernia that’s absent or small (large hernias are typically better suited to surgical repair)

ARMA vs. Other Endoscopic Options — A Quick Note

It’s worth knowing that ARMA is one of several newer endoscopic anti-reflux approaches, and it’s sometimes confused with other device-based procedures that treat the same general problem differently. For example, systems that perform endoscopic full-thickness plication work by mechanically stitching or folding tissue at the junction, rather than using thermal ablation. Both aim to reinforce the same anti-reflux barrier, but the mechanism, tools, and healing process differ. If you’re researching options, it’s worth asking your gastroenterologist specifically which technique a given device or procedure uses.

The Bottom Line

ARMA represents a genuinely novel middle path for GERD treatment — less invasive than surgery, but more durable than relying on medication alone for those who aren’t getting full relief from PPIs. As with any relatively new procedure, it’s best discussed with a gastroenterologist who can review your specific anatomy, reflux severity, and treatment history to determine if you’re a good candidate.

Digital